Aldeyra Therapeutics Inc.

NASDAQ: ALDX · Real-Time Price · USD
2.10
-0.05 (-2.33%)
At close: Jun 02, 2025, 3:59 PM
2.12
0.71%
After-hours: Jun 02, 2025, 07:41 PM EDT
-2.33%
Bid 2.09
Market Cap 126.08M
Revenue (ttm) 244.53K
Net Income (ttm) -57.7M
EPS (ttm) -0.97
PE Ratio (ttm) -2.17
Forward PE 19.5
Analyst Buy
Ask 2.12
Volume 932,057
Avg. Volume (20D) 1,803,223
Open 2.15
Previous Close 2.15
Day's Range 2.08 - 2.26
52-Week Range 1.14 - 7.20
Beta 0.68

About ALDX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALDX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ALDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 months ago
-73.36%
Aldeyra Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
6 months ago
+11.64%
Aldeyra Therapeutics shares are trading higher after the FDA accepted its resubmitted new drug application for Reproxalap for the treatment of dry eye disease, prompting the company to announce an expansion of its option agreement with AbbVie.